Deals & business · first seen 1h ago, updated 1h ago
Alnylam alumni-led RNAi biotech City Therapeutics files for IPO
Biotechs are rushing into the IPO queue. City Therapeutics submitted its public pitch late Thursday, the same night ADARx Pharmaceuticals priced its $446 million Nasdaq debut. Kendall Square-based ...
Summary from Endpoints News.